Evidence map›Paper›PMID 34637319›Full record

ArticleMolecular pharmaceutics2021

Molecular Flexibility of Antibodies Preserved Even in the Dense Phase after Macroscopic Phase Separation.

Anita Girelli, Christian Beck, Famke Bäuerle, Olga Matsarskaia, Ralph Maier, Fajun Zhang, Baohu Wu, Christian Lang, Orsolya Czakkel, Tilo Seydel and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Anita GirelliInstitut für Angewandte Physik, Universität Tübingen, Auf der Morgenstelle 10, 72076 Tübingen, Germany.
Christian BeckInstitut für Angewandte Physik, Universität Tübingen, Auf der Morgenstelle 10, 72076 Tübingen, Germany.ORCID 0000-0001-7214-3447
Famke BäuerleInstitut für Angewandte Physik, Universität Tübingen, Auf der Morgenstelle 10, 72076 Tübingen, Germany.
Olga MatsarskaiaInstitut Laue-Langevin, 71 Avenue des Martyrs, 38042 Grenoble, France.ORCID 0000-0002-7293-7287
Ralph MaierInstitut für Angewandte Physik, Universität Tübingen, Auf der Morgenstelle 10, 72076 Tübingen, Germany.ORCID 0000-0003-3428-039X
Fajun ZhangInstitut für Angewandte Physik, Universität Tübingen, Auf der Morgenstelle 10, 72076 Tübingen, Germany.ORCID 0000-0001-7639-8594
Baohu WuJülich Centre for Neutron Science JCNS at MLZ, Forschungszentrum Jülich, Lichtenbergstraße 1, 85748 Garching, Germany.
Christian LangJülich Centre for Neutron Science JCNS at MLZ, Forschungszentrum Jülich, Lichtenbergstraße 1, 85748 Garching, Germany.ORCID 0000-0002-8220-6568
Orsolya CzakkelInstitut Laue-Langevin, 71 Avenue des Martyrs, 38042 Grenoble, France.
Tilo SeydelInstitut Laue-Langevin, 71 Avenue des Martyrs, 38042 Grenoble, France.ORCID 0000-0001-9630-1630
Frank SchreiberInstitut für Angewandte Physik, Universität Tübingen, Auf der Morgenstelle 10, 72076 Tübingen, Germany.ORCID 0000-0003-3659-6718
Felix Roosen-RungeDepartment of Biomedical Science and Biofilms-Research Center for Biointerfaces (BRCB), Malmö University, 205 06 Malmö, Sweden.ORCID 0000-0001-5106-4360
University of Tübingen · DEInstitut Laue-Langevin · FRForschungszentrum Jülich · DEMalmö University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibody therapies are typically based on high-concentration formulations that need to be administered subcutaneously. These conditions induce several challenges, inter alia a viscosity suitable for injection, sufficient solution stability, and preservation of molecular function. To obtain systematic insights into the molecular factors, we study the dynamics on the molecular level under strongly varying solution conditions. In particular, we use solutions of antibodies with poly(ethylene glycol), in which simple cooling from room temperature to freezing temperatures induces a transition from a well-dispersed solution into a phase-separated and macroscopically arrested system. Using quasi-elastic neutron scattering during

Indexed as

Antibodies, MonoclonalChemistry, PharmaceuticalDiffusionInjections, SubcutaneousNeutronsPharmaceutical VehiclesPolyethylene GlycolsSolutionsSpectrum AnalysisViscosityAntibodies, MonoclonalPharmaceutical VehiclesPolyethylene GlycolsSolutionsantibody therapydiffusiondynamicsmolecular flexibility

Identifiers

PMID34637319
PMCPMC8564753
OpenAlexW3205860462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.